COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.

Agenda Cardiovascular Atherosclerosis 2021

Saturday, June 19, 2021

7 a.m.

Non-CME Lecture

LP(a) – A Novel Biomarker with Great Clinical Promise

Sotirios Tsimikas, MD

7:30 a.m.

Virtual Event Opens & View Exhibits

7:55 a.m.

Welcome and Introductions

David P. Cork, MD and Christopher J. Suhar, MD


8 a.m.

New Concepts in Dyslipidemia: Dispelling 10 Common Health “Truths” About Lipids and Risk Assessment

Douglas W. Triffon, MD

8:30 a.m.

Influence of Elevated Triglycerides on Atherosclerosis and Non-Statin Therapies - Review of Data: Omega 3, Bempedoic Acid, Niacin, Ezetimibe, PCSK9 Inhibitors

David P. Cork, MD

9 a.m.

Evaluation of Subclinical Coronary Atherosclerosis, Coronary CTA and Coronary Calcium Score

Jorge A. Gonzalez, MD

9:30 a.m.

Panel Discussion & Q/A

9:45 a.m.

Break & View Exhibits

10:05 a.m.

Exercise and Cardiovascular Risk

Christopher J. Suhar, MD

10:35 a.m.

Cardiovascular Prevention in Women

Poulina Q. Uddin, MD

11:05 a.m.

Optimizing Dietary Pattern in Patients with Cardiovascular Disease

Sandeep R. Mehta, MD

11:45 a.m.

Panel Discussion & Q/A


Break & View Exhibits

12:15 p.m.

Cardiometabolic Disease and Novel Therapies: SGLT2 Inhibitors and GLP1 Agonists

Daniel Einhorn, MD

12:45 p.m.

Update on Inflammation and Novel Biomarkers for Atherosclerosis

Douglas W. Triffon, MD

1:15 p.m.

The Utility of Polygenic Risk Scores in Primary Prevention of Atherosclerotic Cardiovascular Disease

Amitabh C. Pandey, MD

1:45 p.m.

Panel Discussion & Q/A

2 p.m.


2-3 p.m.

Non-CME Symposium Hosted by ESPERION

An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C

Matthew Budoff, MD

Please note: All times listed are Pacific Standard Time (PST)